Caliway Biopharmaceuticals Co., Ltd. logo

Caliway Biopharmaceuticals Co., Ltd. (6919)

Market Closed
2 Dec, 05:30
TWSE TWSE
NT$
611. 00
+10
+1.6639%
NT$
- Market Cap
- P/E Ratio
0.1% Div Yield
622,615 Volume
- Eps
NT$ 601
Previous Close
Add Transaction
Day Range
592 628
Year Range
240.5 800
Want to track 6919 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Caliway Biopharmaceuticals Co., Ltd. logo
6919 Caliway Biopharmaceuticals Co., Ltd.
18 May 2026
-
-
Caliway Biopharmaceuticals Co., Ltd. logo
6919 Caliway Biopharmaceuticals Co., Ltd.
9 Apr 2026
-
-
Caliway Biopharmaceuticals Co., Ltd. logo
6919 Caliway Biopharmaceuticals Co., Ltd.
10 Nov 2025
-
-
Caliway Biopharmaceuticals Co., Ltd. logo
6919 Caliway Biopharmaceuticals Co., Ltd.
11 Aug 2025
-
-

6919 Earnings Reports FAQ

What is the earnings per share (EPS) for 6919?

EPS data for 6919 is currently not available, as Caliway Biopharmaceuticals Co., Ltd has not reported recent earnings.

What is the company's earnings growth rate?

Caliway Biopharmaceuticals Co., Ltd has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Caliway Biopharmaceuticals Co., Ltd has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Caliway Biopharmaceuticals Co., Ltd are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for 6919 at this time, as Caliway Biopharmaceuticals Co., Ltd has no recent EPS data to calculate it.